Tech Company Financing Transactions

Lanx Funding Round

Credit Suisse, Chicago Growth Partners and Goldman Sachs participated in a $15 million Series C funding round for Lanx. The round was announced by the company on 5/13/2013.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Proceeds will be used for continued growth of the sales and marketing infrastructure and further expansion of the Company's comprehensive product suite across both minimally invasive and core spinal fusion.

Company Information

Company Status
Acquired or Merged
Medical Devices & Instruments
Mailing Address
310 Interlocken Crescent 120
Broomfield, CO 80021
Email Address
Lanx, LLC is a medical device company developing and marketing surgical implants and biological products for spinal surgery. The Company currently markets 15 product lines of implants and associated instrumentation for spinal fusion surgery.
Lanx LinkedIn Company Profile
Social Media
Lanx Company Twitter Account
Company News
Lanx News
Lanx on Facebook
Lanx on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Fulton
  Michael Fulton LinkedIn Profile  Michael Fulton Twitter Account  Michael Fulton News  Michael Fulton on Facebook
VP - Human Resources
Judy Wodell
  Judy Wodell LinkedIn Profile  Judy Wodell Twitter Account  Judy Wodell News  Judy Wodell on Facebook



Browse more venture capital transactions:

Prev: 5/11/2013: GiveCorps venture capital transaction
Next: 5/13/2013: GetMyRx venture capital transaction


Share this article


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary